Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A new version entry v3.6.0 was added to the study history with a note that the study is no longer looking for participants. The previous version (v3.5.5) was removed from the history.
    Difference
    0.3%
    Check dated 2026-06-12T16:30:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The revision history now shows the latest version as v3.5.5, replacing the previous v3.5.4 in the record's metadata.
    Difference
    0.1%
    Check dated 2026-06-05T13:27:28.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.4) was added to the record history and a previous revision (v3.5.3) was removed, indicating a minor update to the page's revision-tracking rather than to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T09:18:52.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page’s displayed software/version label is updated from v3.5.2 to v3.5.3, reflecting a maintenance or release revision without changing the study record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:18:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:28.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T08:36:39.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.